

$25,000 Follistatin Gene Therapy - Before & After Results Analysis With Peter Attia
Jan 2, 2025
In this engaging conversation, Peter Attia, a renowned physician and researcher focused on longevity, dives into the groundbreaking world of gene therapy targeting follistatin. He explains how inhibiting myostatin could revolutionize muscle growth but warns of the hype surrounding its commercialization. The discussion sheds light on the often misleading practices in fitness photography and critiques inflated claims of gene therapy results. Attia emphasizes the importance of scientific validation, especially regarding the unexpected metabolic effects observed in users.
AI Snips
Chapters
Transcript
Episode notes
Myostatin Knockout Phenotype
- Myostatin knockout mice and cattle exhibit a "double muscle" phenotype.
- This phenotype results in significantly increased muscle mass, leading to an exaggerated, almost Photoshopped appearance.
Folistatin and Muscle Growth
- A gene therapy aims to increase folistatin, which inhibits myostatin, potentially promoting muscle growth.
- However, a gray market folistatin peptide exists, with anecdotal reports of muscle gain, but no solid scientific data supporting its effectiveness.
Research Chemical Folistatin
- Research chemical companies created and sold folistatin peptides, despite lacking scientific evidence of effectiveness.
- People spent thousands of dollars on folistatin cycles, but results were generally unimpressive, with occasional exaggerated claims.